The company’s flagship Indocyanine Green (“ICG”) product (marketed as IC-GREEN® in the US, Indocyanine Green for Injection, USP in the US and Canada and Verdye outside North America) is the most widely-used fluorescence agent in FGS, according to Frost & Sullivan.
UltraGreen.ai has lodged its preliminary prospectus with the Monetary Authority of Singapore (MAS) for its proposed listing on the mainboard of the Singapore Exchange Securities Trading (SGX-ST).
UltraGreen.ai is a global leader in the fluorescence-guided surgery (“FGS”) space, pioneering vertical AI tools for precision surgery using data-driven fluorescence imaging solutions. The company offers a fluorescence imaging ecosystem that empowers surgeons with enhanced precision and real-time perfusion data, ultimately improving patient outcomes.
